Literature DB >> 6087925

Metabolic effects and cyclic AMP levels produced by glucagon, (1-N alpha-Trinitrophenylhistidine,12-homoarginine)glucagon and forskolin in isolated rat hepatocytes.

S Corvera, J Huerta-Bahena, J T Pelton, V J Hruby, D Trivedi, J A García-Sáinz.   

Abstract

[1-N alpha-Trinitrophenylhistidine,12-homoarginine]glucagon (THG) is a potent antagonist of the effects of glucagon on liver membrane adenylate cyclase. In isolated hepatocytes, this glucagon analogue was an extremely weak partial agonist for cAMP accumulation, and it blocked the stimulation of cAMP accumulation produced by glucagon. However, THG was a full agonist for the stimulation of glycogenolysis, gluconeogenesis and urea synthesis in rat hepatocytes, and did not antagonize the metabolic effects of glucagon under most of the conditions examined. Forskolin potentiated the stimulation of cAMP accumulation produced by glucagon or THG, but did not potentiate their metabolic actions. A much larger increase in cAMP levels seemed to be required for the stimulation of hepatocyte metabolism by forskolin than by glucagon or THG. This may suggest the existence of a functional compartmentation of cAMP in rat hepatocytes. The possible existence of compartments in cAMP-mediated hormone actions and the involvement of factors, besides cAMP, in mediating the effects of THG and glucagon is suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087925     DOI: 10.1016/0167-4889(84)90071-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.

Authors:  G Paolisso; S Buonocore; S Gentile; S Sgambato; M Varricchio; A Scheen; F D'Onofrio; P J Lefèbvre
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Interpretation of dose-response curves for luteinizing hormone release by gonadotropin-releasing hormone, related peptides, and leukotriene C4 according to a hormone/receptor/effector model.

Authors:  J Leiser; P M Conn; J J Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.

Authors:  G J Murphy; V J Hruby; D Trivedi; M J Wakelam; M D Houslay
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  Calcium rather than cyclic AMP is an intracellular messenger of parathyroid hormone action on glycogen metabolism in isolated rat hepatocytes.

Authors:  T Mine; I Kojima; E Ogata
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

Review 5.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

6.  Modulation of glucagon-induced glucose production by dexfenfluramine in rat hepatocytes.

Authors:  B Comte; A Romanelli; S Tchu; G van de Werve
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Effects of phorbol esters on alpha 1-adrenergic-mediated and glucagon-mediated actions in isolated rat hepatocytes.

Authors:  J A García-Sáinz; F Mendlovic; M A Martínez-Olmedo
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

8.  Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity.

Authors:  M Robles-Flores; G Allende; E Piña; J A García-Sáinz
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

9.  Effect of glucagon on intracellular pH regulation in isolated rat hepatocyte couplets.

Authors:  D Alvaro; P Della Guardia; A Bini; A Gigliozzi; S Furfaro; T La Rosa; C Piat; L Capocaccia
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3.

Authors:  Wei Xie; Yangliang Ye; Ying Feng; Tifei Xu; Suling Huang; Jianhua Shen; Ying Leng
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.